WALLACE RHEUMATIC DISEASE FOUNDATI… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2012

Legal Domicile

Principal Officer

DANIEL WALLACE

Phone

7472033377

Tax Period

2025-01-01 to 2025-12-31

WALLACE RHEUMATIC DISEASE FOUNDATION, founded in 2012, is a small nonprofit in the Medical Research sector that reported $188K in total revenue in fiscal year 2025. Revenue surged 28% from the prior year, signaling strong growth momentum. The organization ran a surplus of $61K, a strong 32% operating margin.

Mission

FUNDING CUTTING-EDGE RESEARCH, FELLOWSHIP PROGRAMS AND PATIENT ACCESS TO CARE GRANTS.

Program Service Accomplishments

Program 1

Expenses: $7,500

FUNDING OR POSTGRADUATE TRAINING TO RHEUMATOLOGY FELLOWS, PROVIDING GRANTS FOR MEDICAL CARE

Program 2

Expenses: $2,000

FUNDING FOR MEDICAL CARE

Program 3

Expenses: $1,200

PROVIDING GRANTS FOR UNINSURED OR UNDERINSURED PATIENTS WITH AUTOIMMUNE DISEASE

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $187,995

Program Service Revenue $0

Investment Income $40

Other Revenue $0

TOTAL REVENUE $188,035

Expense Breakdown

Grants Paid $12,200

Salaries & Benefits $30,000

Fundraising Expenses $0

Program Expenses $12,200

Other Expenses $84,806

TOTAL EXPENSES $127,006

Year-over-Year Comparison

	2025	2024	Change
Revenue	$188,035	$146,836	+0.3%
Expenses	$127,006	$221,621	-0.4%
Net Income	$61,029	$-74,785	-1.8%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

$30,000

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DANIEL WALLACE	PRESIDENT	1.00	Director	$30,000	$0	$30,000

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$188,035	$127,006	$100,755	$61,029
2024	$146,836	$221,621	$39,726	$-74,785
2020	$257,399	$297,142	$153,617	$-39,743
2019	$253,779	$238,957	$188,258	$14,822
2018	$243,770	$229,524	$173,435	$14,246

WALLACE RHEUMATIC DISEASE FOUNDATION